Reasons for Switchback from Generic to Brand-Name Drugs in a Cohort of Patients Treated by Allopurinol

被引：0
|
作者：
Laroche, M. L. [1 ]
Crepin, S. [1 ]
Deysson, M. [2 ]
Merle, L. [1 ]
机构：
[1] Reg Ctr Pharmacovigilance, Limoges, France
[2] Med Unit Reg Hlth Insurance, Limoges, France
来源：
DRUG SAFETY | 2009年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
70
引用
收藏
页码：905 / 906
页数：2
相关论文
共 50 条
  • [1] Economic Impact of Switchback from Generic to Brand-Name Drugs: Example of Allopurinol
    Laroche, M. L.
    Crepin, S.
    Deysson, M.
    Merle, L.
    [J]. DRUG SAFETY, 2009, 32 (10) : 905 - 905
  • [2] Reasons for switching from a generic to a brand-name drug:: example of allopurinol
    Laroche, M. L.
    Crepin, S.
    Rolland, G.
    Merle, L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 22 - 22
  • [3] Brand-Name Versus Generic Drugs
    Manning, Richard
    Smith, Richard
    [J]. HEALTH AFFAIRS, 2011, 30 (10) : 2027 - 2027
  • [4] UNIFORM APPEARANCE OF GENERIC AND BRAND-NAME DRUGS
    KAHN, BS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (26): : 1492 - 1492
  • [5] Inadequate labels: Brand-name and generic drugs
    Kazhdan, Daniel
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [6] A brand-name generic
    Savage, PR
    [J]. IEEE SPECTRUM, 2004, 41 (10) : 60 - 61
  • [7] GENERIC VS BRAND-NAME DRUGS FOR THE TREATMENT OF HYPERTENSION
    Dinic, M.
    Maillard, N.
    Bouiller, M.
    Alamartine, E.
    Mariat, C.
    [J]. JOURNAL OF HYPERTENSION, 2018, 36 : E123 - E123
  • [8] The effect of generic competition on the price of brand-name drugs
    Lexchin, J
    [J]. HEALTH POLICY, 2004, 68 (01) : 47 - 54
  • [9] Dispensing pattern of generic and brand-name drugs in children
    Chen, Alex Y.
    Wu, Susan
    [J]. AMBULATORY PEDIATRICS, 2008, 8 (03) : 189 - 194
  • [10] Brand-Name and Generic Drugs Not Equivalent in Malpractice Claims
    Vivian, Jesse C.
    [J]. US PHARMACIST, 2011, 36 (09) : 49 - 51
12345